Top 10 Companies in the HDPE for Capsule Market (2026): Market Leaders Powering Global Drug Delivery

Global HDPE for Capsule market was valued at USD 1,597 million in 2025 and is projected to reach USD 2,262 million by 2034, growing at a compound annual growth rate (CAGR) of 5.2%.

HDPE for Capsule Market – View in Detailed Research Report

The market’s growth can be attributed to increasing demand for pharmaceutical capsules, particularly in emerging markets where healthcare access is expanding. The rise in the aging population worldwide has also fueled demand for drug delivery systems that are both effective and safe, such as HDPE-based capsules.

As a robust and cost‑effective material, HDPE is gaining popularity in the pharmaceutical industry for encapsulating both solid and liquid‑based medicines. The growing adoption of capsules over traditional tablet forms, due to their ease of consumption and quick dissolution rates, is also contributing to the market’s expansion.

High‑Density Polyethylene (HDPE) is a widely used plastic known for its robustness and high tensile strength. HDPE for capsules specifically refers to the use of HDPE material in the production of pharmaceutical capsules. These capsules, typically in the form of hard gelatin capsules, are used for encapsulating medications in the pharmaceutical industry. HDPE is preferred due to its exceptional chemical resistance, durability, and ability to be molded into various shapes, making it ideal for protecting sensitive medications.

The material is derived from petroleum and processed into a solid, rigid polymer that can withstand both high temperatures and physical stress. HDPE for capsules plays a vital role in ensuring the stability and controlled release of medicines, providing consumers with safer and more effective drug delivery systems. Moreover, the ability of HDPE to be recycled has made it a sustainable choice for the pharmaceutical industry.

🔟 1. BASF SE

Headquarters: Ludwigshafen, Germany
Key Offering: High‑performance HDPE grades for pharmaceutical capsules

BASF’s advanced polymer technologies enable consistent capsule integrity and controlled release, meeting stringent quality requirements of global pharmaceutical manufacturers.

Sustainability Initiatives:

• Develops bio‑based HDPE variants
• Implements CO₂‑neutral manufacturing
• Partners with pharma for end‑to‑end recycling

9️⃣ 2. Lonza Group

Headquarters: Basel, Switzerland
Key Offering: Capsule manufacturing solutions using HDPE

Lonza’s integrated production platform supports scalable capsule production, ensuring reliable supply for large‑volume pharmaceutical clients.

Sustainability Initiatives:

• Energy‑efficient production lines
• Closed‑loop water usage
• Collaborations with pharma for waste reduction

8️⃣ 3. Capsugel (now part of Lonza)

Headquarters: Zurich, Switzerland
Key Offering: Specialized capsule technologies

Capsugel’s expertise in capsule design enhances drug stability and facilitates regulatory approvals for a wide range of therapeutic areas.

Sustainability Initiatives:

• Green solvent processes
• Low‑energy curing
• Supports pharma in sustainability reporting

7️⃣ 4. Suheung Co., Ltd.

Headquarters: Seoul, South Korea
Key Offering: Custom HDPE capsules for niche therapeutic areas

Suheung’s flexible manufacturing accommodates personalized medicine, enabling rapid response to emerging therapeutic needs.

Sustainability Initiatives:

• Recycled content up to 30%
• ISO 14001 certification
• Supplier partnership for waste minimization

6️⃣ 5. Bayer AG

Headquarters: Leverkusen, Germany
Key Offering: Pharmaceutical ingredients and packaging solutions

Bayer integrates HDPE capsule production into its drug development pipeline, ensuring seamless transition from formulation to final product.

Sustainability Initiatives:

• Renewable energy usage
• Life‑cycle assessment of packaging
• Circular packaging initiatives

5️⃣ 6. Evonik Industries

Headquarters: Essen, Germany
Key Offering: Specialty polymers for drug delivery

Evonik’s HDPE blends improve capsule mechanical strength while maintaining biocompatibility, supporting high‑quality pharmaceutical products.

Sustainability Initiatives:

• Low‑VOC polymerization processes
• Carbon‑offset programs
• Collaboration with pharma for material reuse

4️⃣ 7. Dow Chemical

Headquarters: Midland, Michigan, USA
Key Offering: Polyethylene solutions for medical devices

Dow’s HDPE grades support robust capsule manufacturing, offering high purity and consistent performance across large production volumes.

Sustainability Initiatives:

• Recycling infrastructure for HDPE
• Sustainable feedstock sourcing
• Partnerships with pharma for circularity

3️⃣ 8. DuPont

Headquarters: Wilmington, Delaware, USA
Key Offering: Advanced polymer technologies

DuPont’s HDPE formulations enhance capsule durability and protect sensitive medications from environmental stressors.

Sustainability Initiatives:

• Bio‑based polymer content
• Energy‑efficient processing
• Collaboration with pharma for green packaging

2️⃣ 9. DSM

Headquarters: Heerlen, Netherlands
Key Offering: Polymer solutions for drug delivery

DSM’s HDPE materials provide consistent capsule quality, supporting high‑throughput manufacturing for global pharmaceutical markets.

Sustainability Initiatives:

• Carbon‑negative production
• Life‑cycle impact reduction
• Partnerships with pharma for circular supply chains

1️⃣ 10. LyondellBasell

Headquarters: Rotterdam, Netherlands
Key Offering: Polyethylene production for pharmaceutical use

LyondellBasell’s HDPE offers high purity and scalability, enabling manufacturers to meet growing demand for capsule‑based drug delivery.

Sustainability Initiatives:

• Recycled content in production
• Energy‑efficient plants
• Collaboration with pharma for waste reduction

Download FREE Sample Report: HDPE for Capsule Market – View in Detailed Research Report

Get Full Report: HDPE for Capsule Market – View in Detailed Research Report

🌍 Outlook: The Future of HDPE for Capsule

The HDPE for Capsule market is poised to evolve as pharmaceutical manufacturers prioritize safety, efficacy, and sustainability in drug delivery. The convergence of regulatory rigor, technological innovation, and consumer demand for personalized medicine will shape the trajectory of this segment.

📈 Key Trends Shaping the Market:

• Adoption of bio‑based HDPE to reduce carbon footprint
• Integration of smart capsule technologies for real‑time monitoring of drug release
• Expansion of HDPE capsule usage in emerging therapeutic areas such as oncology and neurology
• Strengthening of circular economy initiatives across the pharmaceutical supply chain